EGF or HRG have been reported to promote CXCR4 serine and/or tyrosine phosphorylation in glioblastoma or BC cells leading to CXCL12-independent receptor activation of downstream cascades [16,57,58,59]. The gene discussed is HRG; the disease is breast cancer.